In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 14, 2024), Finepoint Capital LP reported 17 stock positions worth $376.0 million . Its top holding was Liberty Broadband-C (LBRDK) at 28.7% of the portfolio, followed by Springworks Therapeutics (SWTX, 7.8% ) and Ascendis Pharma A/S (ASND, 7.1% ). Compared with Q4 2023, it opened 2 new positions, sold out of 2, added to 11 and reduced 2. The biggest buy was Liberty Broadband-C (LBRDK, shares +923% ) and the biggest sale Cytokinetics (CYTK, shares −45% ).
Location BOSTON, MA
CIK 0001608126
Portfolio Value $376.0M (Q1 2024) Holdings 17 stocks · $376.0M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q4 2023 LBRDK Liberty Broadband-C 1,886,260 $108.0M Add +922.6% SWTX Springworks Therapeutics Inc. 592,528 $29.2M Add +6.4% ASND Ascendis Pharma A/S 175,672 $26.6M Add +7.3% ARVN Arvinas Inc. 539,100 $22.3M Add +6.8% RVMD Revolution Medicines Inc. 677,100 $21.8M Add +9.7% SRPT Sarepta Therapeutics Inc. 158,457 $20.5M Add +9.0% ARGX Argenx SE - ADR 50,000 $19.7M New MLTX Moonlake Immunotherapeutics 360,916 $18.1M Reduce -59.7% CYTK Cytokinetics Inc. 238,046 $16.7M Reduce -44.9% LKFT Lakefront Biotherapeutic-ADR filed as GALAPAGOS NV 503,759 $16.2M Add +9.8% ACAD Acadia Pharmaceuticals Inc. 840,453 $15.5M Add +9.2% EYPT Eyepoint Inc. 656,600 $13.6M New SLDB Solid Biosciences Inc. 961,251 $12.8M No change TVTX Travere Therapeutics Inc. 1,649,221 $12.7M Add +14.9% RLAY Relay Therapeutics Inc. 1,490,170 $12.4M Add +13.1% PRTA Prothena Corp. PLC 402,400 $10.0M Add +15.2% CALIDI BIOTHERAPEUTICS INC 125,000 $71K No change
Other holdings (9): bonds, preferreds, convertibles and warrants · $13.9M (not counted above) Security Class Shares / Principal Value Change DISH NETWORK CORP (DISH 0 12/15/25) NOTE 12/1 · principal 18,300,000 $13.5M New CVIIW Churchill Capital Vii -CW28 *W EXP 02/29/202 548,000 $175K No change MNYWW Moneyhero Ltd.-28 *W EXP 09/13/202 895,000 $108K New CNDAW Concord Acquisition A -CW28 *W EXP 99/99/999 408,333 $45K No change CDAWF Compass Digital Acq -CW28 *W EXP 99/99/999 459,906 $42K No change CLDWW Calidi Biotherapeutics -CW23 *W EXP 03/14/202 655,200 $34K No change IVCPW Swiftmerge Acquisition -CW23 *W EXP 12/13/202 490,000 $27K No change LAKESHORE BIOPHARMA CO LTD *W EXP 03/15/202 489,999 $25K No change GATEW Marblegate Acquisition -CW22 *W EXP 08/31/202 735,000 $8K No change
Total filed on the 13F, all lines: $389.9M.
Portfolio Sells Q4 2023 → Q1 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2023 % Of Portfolio Change To Portfolio ▲ CYTK Cytokinetics Inc. Reduce -44.9% 4.44% −8.97 FOLD Amicus Therapeutics Inc. Sold out 0.00% −7.86 MORF Morphic Holding Inc. Sold out 0.00% −5.34 MLTX Moonlake Immunotherapeutics Reduce -59.7% 4.82% +4.80
Portfolio Buys Q4 2023 → Q1 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2023 % Of Portfolio Change To Portfolio ▼ LBRDK Liberty Broadband-C Add +922.6% 28.71% +23.18 ARGX Argenx SE - ADR New 5.24% +5.24 EYPT Eyepoint Inc. New 3.61% +3.61 SRPT Sarepta Therapeutics Inc. Add +9.0% 5.46% +0.24 SWTX Springworks Therapeutics Inc. Add +6.4% 7.76% +0.19 ASND Ascendis Pharma A/S Add +7.3% 7.06% −0.61 RVMD Revolution Medicines Inc. Add +9.7% 5.80% −0.78 TVTX Travere Therapeutics Inc. Add +14.9% 3.38% −1.42 ARVN Arvinas Inc. Add +6.8% 5.92% −1.81 PRTA Prothena Corp. PLC Add +15.2% 2.65% −2.07 RLAY Relay Therapeutics Inc. Add +13.1% 3.29% −2.11 LKFT Lakefront Biotherapeutic-ADR Add +9.8% 4.31% −2.62 ACAD Acadia Pharmaceuticals Inc. Add +9.2% 4.13% −4.83
Options Activity Q4 2023 → Q1 2024 Security Type Change vs Q4 2023 Underlying Shares Value ▼ SAVEQ Spirit Airlines Inc. call Sold out 1,700,000 $27.9Mbefore exit
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q4 2023 → Q1 2024 Security Class Change vs Q4 2023 Shares / Principal Value ▼ HPLTW Home Plate Acq -CW23 *W EXP 09/30/202 Sold out 331,416 $20.0Mbefore exit DISH NETWORK CORP (DISH 0 12/15/25) NOTE 12/1 · principal New 18,300,000 $13.5M MNYWW Moneyhero Ltd.-28 *W EXP 09/13/202 New 895,000 $108K ROSS.WS Ross Acquisition Corp. -CW26 *W EXP 02/01/202 Sold out 439,666 $25Kbefore exit
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 4 $460.8M QXO, RXO, ANNA, CLDI Q1 2026 4 $416.6M QXO, RXO, ANNA, CLDI Q4 2025 5 $532.7M QXO, RXO, SLDB, ANNA, CLDI Q3 2025 5 $542.8M QXO, RXO, SLDB, ANNA, CLDI Q2 2025 5 $504.1M QXO, LLYVK, SLDB, ANNA, CLDI Q1 2025 19 $592.5M QXO, LBRDK, SWTX, LLYVK, ASND Q4 2024 20 $866.7M QXO, LBRDK, LLYVK, ARGX, RVMD Q3 2024 18 $822.2M QXO, LBRDK, RVMD, ARGX, ASND Q2 2024 17 $351.8M LBRDK, RVMD, ASND, SWTX, ARGX Q1 2024 17 $376.0M LBRDK, SWTX, ASND, ARVN, RVMD